<DOC>
	<DOCNO>NCT02241421</DOCNO>
	<brief_summary>BACKGROUND : The relation gut microbiota obesity originate animal study , show change gut microbiota induce change insulin resistance body composition . In addition , study show change gut permeability induce pro-inflammatory state , change adipose tissue function inflammation , effect energy harvest metabolism , skeletal muscle fatty acid partition fat oxidation . Human data lacking , although several study suggest composition gut microbiota differs lean obese , diabetic non-diabetic individual . OBJECTIVE : To provide insight physiological significance underlie mechanism involve relation gut microbiota , energy balance insulin sensitivity overweight men impair glucose homeostasis .</brief_summary>
	<brief_title>The Importance Gut Microbiota Body Weight Control Insulin Sensitivity</brief_title>
	<detailed_description>The view putative significance gut microbiota metabolism emerge animal study . Bäcked et al . show germ free mouse 40 % less body fat compare conventionally raise mouse . Transplantation cecum-derived microbial community conventional mice germ free mouse , result significant increase body weight insulin resistance within 2 week . Application metagenomic technique leptin-deficient ob/ob mouse show different proportion bacteria belong compare lean , wild-type heterozygous mouse , great representation Firmicutes few Bacteroidetes . This obese gut microbiome show enrichment gene involve energy extraction food , less energy leave faeces high content short-chain fatty acid ( SCFAs ) propionate , acetate butyrate cecum . Furthermore , microbiota composition may alter gut permeability , may play role development metabolic endotoxemia ( inflammation ) relate impairment glucose metabolism . In addition , gut microbiota may determine AMP-activated protein kinase ( AMPK ) level muscle liver , thereby affect fatty acid oxidation ( substrate metabolism ) fat storage . However , underlie mechanism completely understood . Therefore , researcher within Top Institute Food Nutrition ( TIFN ) design multidisciplinary project ( 'Microbiota , energy balance metabolism ' ) , fill unmet gap gut microbiota human energy metabolism . The current protocol design clarify role gut microbiota host energy metabolism insulin sensitivity , main focus underlie mechanism .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>male 3570 year caucasian overweight/obese ( BMI 2535 kg/m2 ) insulin resistant ( Homeostasis Model Assessment Insulin Resistance ( HOMA_IR ) &gt; 2.2 ) impair glucose tolerance ( IGT : 2h plasma glucose 75g Oral Glucose Tolerance Test ( OGTT ) 7.811.1 mmol/l ) and/or impair fast glucose ( plasma glucose ≥ 5.6 mmol/l ) body weight stable least three month ( ±3 kg ) know allergic reaction vancomycin , teicoplanin , amoxicillin βlactam antibiotic ( penicillin cefalosporins ) relate antibiotic diabetes mellitus hear disorder cardiovascular disease kidney disease gastrointestinal disease cancer asthma bronchitis liver malfunction major illness life expectancy &lt; 5 year diseases affect glucose tolerance ( e.g . pheochromocytoma , Cushing 's syndrome , acromegaly ) , use antibiotic past 3 month plan lose weight participation organize sport activity &gt; 3 hour per week The use βblockers , lipid loweringdrugs , glucoselowering agent ( include sulfonylurea , biguanides , αglucosidase inhibitor , thiazolidinediones , repaglinide , nateglinide insulin ) , antioxidants chronic corticosteroid treatment ( &gt; 7 consecutive day treatment )</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Impaired glucose tolerance</keyword>
	<keyword>Glucose Metabolism Disorders</keyword>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Endocrine System Diseases</keyword>
	<keyword>Hyperinsulinism</keyword>
	<keyword>Lipid metabolism</keyword>
	<keyword>Anti Bacterial Agents</keyword>
	<keyword>Gastro Intestinal Tract</keyword>
</DOC>